Mwenda Valerian, Mburu Woki, Bor Joan-Paula, Nyangasi Mary, Arbyn Marc, Weyers Steven, Tummers Philippe, Temmerman Marleen
National Cancer Control Program, Ministry of Health, PO Box 30016-00100, Nairobi, Kenya.
Unit of Cancer Epidemiology, Belgian Cancer Centre, Sciensano, Brussels 1050, Belgium.
Ecancermedicalscience. 2022 Aug 26;16:1442. doi: 10.3332/ecancer.2022.1442. eCollection 2022.
Cervical cancer is the leading cause of cancer mortality in Kenya, with an estimated 3,200 deaths in 2020. Kenya has implemented cervical cancer interventions for more than a decade. We describe the evolution of the cervical cancer programme over the last 20 years and assess its performance.
We searched the Ministry of Health's archives and website (2000-2021) for screening policy documents and assessed them using seven items: situational analysis, objectives, key result areas, implementation framework, resource considerations, monitoring and evaluation and definition of roles/responsibilities. In addition, a trend analysis was performed targeting screening and disease burden indicators in the period 2011-2020, using data from Kenya Health Information System and the Global Burden of Disease database.
Policy guidance improved over time, but the implementation of screening was poor. Before 2016, a clear leadership and accountability structure was lacking; improvement occurred after the establishment of the National Cancer Control Program. The main health system gaps included the lack of a trained healthcare workforce and poor data collection. Annual screening coverage varied between <1% and 36% of the target population for the year for HIV-negative women and between <1% and 7% for HIV-positive women, from 2011 to 2020. Test positivity for visual inspection with acetic acid was below 5% for most of the period. Compliance to treatment of precancerous lesions ranged between 22% and 39%. The detection rate of cervical cancer ranged between 0.5% and 1.0%. The burden of invasive cervical cancer did not change significantly: world age-standardised incidence and mortality rates of 26.3-27.4 and 16.6-18.0/100,000 women-years, respectively; disability-adjusted life years of 579-624/100,000 life years.
The Kenyan cervical cancer control programme suffered from inadequate health system strengthening and poor quality implementation. Evidence-based policy implementation and sustained health system strengthening are necessary to move towards cervical cancer elimination as a public health problem.
宫颈癌是肯尼亚癌症死亡的主要原因,2020年估计有3200人死亡。肯尼亚实施宫颈癌干预措施已有十多年。我们描述了过去20年宫颈癌项目的发展历程并评估了其绩效。
我们在卫生部档案和网站(2000 - 2021年)中搜索筛查政策文件,并使用七个项目对其进行评估:形势分析、目标、关键成果领域、实施框架、资源考量、监测与评估以及角色/职责定义。此外,利用肯尼亚卫生信息系统和全球疾病负担数据库的数据,对2011 - 2020年期间的筛查和疾病负担指标进行了趋势分析。
政策指导随时间有所改善,但筛查实施情况较差。2016年之前,缺乏明确的领导和问责结构;国家癌症控制项目设立后有所改善。主要的卫生系统差距包括缺乏训练有素的医疗人员和数据收集不力。2011年至2020年期间,年度筛查覆盖率在艾滋病毒阴性女性目标人群的<1%至36%之间,艾滋病毒阳性女性在<1%至7%之间。大多数时期,醋酸目视检查的检测阳性率低于5%。癌前病变治疗的依从率在22%至39%之间。宫颈癌的检出率在0.5%至1.0%之间。浸润性宫颈癌负担没有显著变化:世界年龄标准化发病率和死亡率分别为每10万女性年26.3 - 27.4和16.6 - 18.0;伤残调整生命年为每10万生命年579 - 624。
肯尼亚宫颈癌控制项目存在卫生系统强化不足和实施质量差的问题。要实现消除宫颈癌这一公共卫生问题的目标,必须实施基于证据的政策并持续加强卫生系统。